MannKind (MNKD) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

MNKD Stock Forecast

MannKind stock forecast is as follows: an average price target of $11.00 (represents a 59.42% upside from MNKD’s last price of $6.90) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

MNKD Price Target

The average price target for MannKind (MNKD) is $11.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $12.00 to $10.00. This represents a potential 59.42% upside from MNKD's last price of $6.90.

MNKD Analyst Ratings

Buy

According to 3 Wall Street analysts, MannKind's rating consensus is 'Buy'. The analyst rating breakdown for MNKD stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

MannKind Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 28, 2024	Steven Lichtman	Oppenheimer	$12.00	$5.38	123.05%	73.91%
Oct 10, 2023	Andreas Argyrides	Wedbush	$10.00	$4.23	136.41%	44.93%

Row per page

Go to

The latest MannKind stock forecast, released on Aug 28, 2024 by Steven Lichtman from Oppenheimer, set a price target of $12.00, which represents a 123.05% increase from the stock price at the time of the forecast ($5.38), and a 73.91% increase from MNKD last price ($6.90).

MannKind Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	1
Avg Price Target	-	$12.00	$12.00
Last Closing Price	$6.90	$6.90	$6.90
Upside/Downside	-100.00%	73.91%	73.91%

In the current month, the average price target of MannKind stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to MannKind's last price of $6.90. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 28, 2024	Oppenheimer	Outperform	Outperform	Hold
Jun 12, 2024	Rodman & Renshaw	-	Buy	Initialise
Oct 10, 2023	Wedbush	-	Outperform	Initialise

Row per page

Go to

MannKind's last stock rating was published by Oppenheimer on Aug 28, 2024. The company gave MNKD a "Outperform" rating, the same as its previous rate.

MannKind Financial Forecast

MannKind Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
Revenue	-	-	-	-	-	-	-	-	$58.47M	$51.25M	$48.61M	$40.63M	$36.06M	$32.83M	$18.89M	$11.99M	$12.52M	$22.21M	$23.28M	$17.44M	$18.44M	$15.35M	$15.11M	$16.23M	$15.99M	$14.60M	$15.00M	$17.45M	$3.46M	$3.01M
Avg Forecast	$87.60M	$83.60M	$77.10M	$73.10M	$74.01M	$73.31M	$64.81M	$60.55M	$53.50M	$50.73M	$42.95M	$37.40M	$35.50M	$25.49M	$15.62M	$10.58M	$17.07M	$19.89M	$17.49M	$15.52M	$16.16M	$15.56M	$14.62M	$14.80M	$15.05M	$15.22M	$14.98M	$13.39M	$3.22M	$2.09M
High Forecast	$88.54M	$84.49M	$77.93M	$73.88M	$74.65M	$76.15M	$65.50M	$60.55M	$57.12M	$50.73M	$43.41M	$37.80M	$35.88M	$25.49M	$15.62M	$10.58M	$17.07M	$19.89M	$17.49M	$15.52M	$16.16M	$15.56M	$14.62M	$14.80M	$15.05M	$15.22M	$14.98M	$13.39M	$3.86M	$2.51M
Low Forecast	$86.83M	$82.86M	$76.42M	$72.46M	$73.37M	$70.48M	$64.24M	$60.55M	$50.59M	$50.73M	$42.57M	$37.07M	$35.19M	$25.49M	$15.62M	$10.58M	$17.07M	$19.89M	$17.49M	$15.52M	$16.16M	$15.56M	$14.62M	$14.80M	$15.05M	$15.22M	$14.98M	$13.39M	$2.58M	$1.68M
# Analysts	1	1	1	1	3	1	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	8	8	8	8	10	15
Surprise %	-	-	-	-	-	-	-	-	1.09%	1.01%	1.13%	1.09%	1.02%	1.29%	1.21%	1.13%	0.73%	1.12%	1.33%	1.12%	1.14%	0.99%	1.03%	1.10%	1.06%	0.96%	1.00%	1.30%	1.08%	1.44%

MannKind's average Quarter revenue forecast for Mar 24 based on 4 analysts is $60.55M, with a low forecast of $60.55M, and a high forecast of $60.55M. MNKD's average Quarter revenue forecast represents a 3.55% increase compared to the company's last Quarter revenue of $58.47M (Dec 23).

MannKind EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	1	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	8	8	8	8	10	15
EBITDA	-	-	-	-	-	-	-	-	$10.63M	$5.10M	$3.38M	$-3.63M	$-8.25M	$-8.86M	$-20.99M	$-21.25M	$-21.95M	$-462.00K	$-30.97M	$-5.50M	$-23.20M	$-8.26M	$-7.03M	$-6.17M	$-11.15M	$-5.13M	$-10.12M	$-12.45M	$-27.48M	$-12.90M
Avg Forecast	$-45.48M	$-43.40M	$-40.02M	$-37.95M	$-38.42M	$-38.06M	$-33.64M	$-30.83M	$-27.78M	$-26.33M	$-22.30M	$-24.37M	$-13.09M	$-12.28M	$-7.53M	$-19.27M	$-8.23M	$-9.58M	$-8.43M	$-4.13M	$-7.78M	$-7.50M	$-7.04M	$-8.23M	$-7.25M	$-7.33M	$-7.22M	$-14.94M	$-25.09M	$-7.27M
High Forecast	$-45.08M	$-43.02M	$-39.67M	$-37.61M	$-38.09M	$-36.59M	$-33.35M	$-24.66M	$-26.26M	$-26.33M	$-22.10M	$-19.50M	$-10.47M	$-12.28M	$-7.53M	$-15.41M	$-8.23M	$-9.58M	$-8.43M	$-3.30M	$-7.78M	$-7.50M	$-7.04M	$-6.58M	$-7.25M	$-7.33M	$-7.22M	$-11.95M	$-20.07M	$-5.82M
Low Forecast	$-45.96M	$-43.86M	$-40.45M	$-38.35M	$-38.75M	$-39.53M	$-34.00M	$-37.00M	$-29.65M	$-26.33M	$-22.53M	$-29.25M	$-15.71M	$-12.28M	$-7.53M	$-23.12M	$-8.23M	$-9.58M	$-8.43M	$-4.95M	$-7.78M	$-7.50M	$-7.04M	$-9.88M	$-7.25M	$-7.33M	$-7.22M	$-17.93M	$-30.11M	$-8.72M
Surprise %	-	-	-	-	-	-	-	-	-0.38%	-0.19%	-0.15%	0.15%	0.63%	0.72%	2.79%	1.10%	2.67%	0.05%	3.68%	1.33%	2.98%	1.10%	1.00%	0.75%	1.54%	0.70%	1.40%	0.83%	1.10%	1.77%

4 analysts predict MNKD's average Quarter EBITDA for Mar 24 to be $-30.83M, with a high of $-24.66M and a low of $-37.00M. This is -389.92% lower than MannKind's previous annual EBITDA (Dec 23) of $10.63M.

MannKind Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	1	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	8	8	8	8	10	15
Net Income	-	-	-	-	-	-	-	-	$1.40M	$1.72M	$-5.26M	$-16.02M	$-23.23M	$-19.71M	$-31.47M	$-31.12M	$-32.20M	$-4.43M	$-35.52M	$-12.92M	$-26.41M	$-11.26M	$-10.25M	$-9.32M	$-14.26M	$-10.37M	$-12.39M	$-14.88M	$-30.39M	$-16.32M
Avg Forecast	$14.23M	$14.23M	$11.39M	$8.54M	$7.97M	$8.54M	$2.28M	$-41.60M	$948.88K	$-4.72M	$-10.82M	$-32.89M	$-16.73M	$-23.48M	$-25.67M	$-26.00M	$-18.30M	$-18.20M	$-12.51M	$-9.69M	$-10.71M	$-12.56M	$-14.20M	$-12.43M	$-18.02M	$-19.66M	$-20.48M	$-17.86M	$-27.74M	$-9.20M
High Forecast	$14.43M	$14.43M	$11.55M	$8.66M	$8.08M	$8.66M	$2.31M	$-33.28M	$962.09K	$-4.66M	$-10.69M	$-26.31M	$-13.39M	$-23.48M	$-25.67M	$-20.80M	$-18.30M	$-18.20M	$-12.51M	$-7.75M	$-10.71M	$-12.56M	$-14.20M	$-9.94M	$-18.02M	$-19.66M	$-20.48M	$-14.29M	$-22.19M	$-7.36M
Low Forecast	$14.07M	$14.07M	$11.26M	$8.44M	$7.88M	$8.44M	$2.25M	$-49.92M	$938.02K	$-4.78M	$-10.97M	$-39.46M	$-20.08M	$-23.48M	$-25.67M	$-31.20M	$-18.30M	$-18.20M	$-12.51M	$-11.62M	$-10.71M	$-12.56M	$-14.20M	$-14.92M	$-18.02M	$-19.66M	$-20.48M	$-21.43M	$-33.29M	$-11.04M
Surprise %	-	-	-	-	-	-	-	-	1.48%	-0.36%	0.49%	0.49%	1.39%	0.84%	1.23%	1.20%	1.76%	0.24%	2.84%	1.33%	2.46%	0.90%	0.72%	0.75%	0.79%	0.53%	0.60%	0.83%	1.10%	1.77%

MannKind's average Quarter net income forecast for Mar 24 is $-41.60M, with a range of $-49.92M to $-33.28M. MNKD's average Quarter net income forecast represents a -3069.50% decrease compared to the company's last Quarter net income of $1.40M (Dec 23).

MannKind SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	1	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	8	8	8	8	10	15
SG&A	-	-	-	-	-	-	-	-	$20.54M	$23.98M	$25.95M	$23.85M	$22.09M	$22.64M	$26.04M	$20.70M	$22.73M	$17.22M	$20.06M	$17.41M	$17.12M	$13.90M	$13.67M	$14.35M	$15.72M	$16.67M	$16.61M	$25.67M	$20.62M	$15.39M
Avg Forecast	$78.98M	$75.37M	$69.51M	$65.90M	$66.73M	$66.10M	$58.43M	$33.12M	$48.24M	$45.74M	$38.72M	$26.18M	$13.55M	$22.98M	$14.09M	$9.54M	$15.39M	$17.93M	$15.77M	$13.06M	$14.57M	$14.03M	$13.18M	$13.34M	$13.57M	$13.72M	$13.51M	$12.08M	$2.90M	$1.89M
High Forecast	$79.82M	$76.18M	$70.26M	$66.61M	$67.30M	$68.66M	$59.06M	$39.74M	$51.50M	$45.74M	$39.14M	$31.42M	$16.26M	$22.98M	$14.09M	$9.54M	$15.39M	$17.93M	$15.77M	$15.67M	$14.57M	$14.03M	$13.18M	$13.34M	$13.57M	$13.72M	$13.51M	$12.08M	$3.48M	$2.27M
Low Forecast	$78.28M	$74.71M	$68.90M	$65.32M	$66.15M	$63.54M	$57.92M	$26.50M	$45.61M	$45.74M	$38.38M	$20.95M	$10.84M	$22.98M	$14.09M	$9.54M	$15.39M	$17.93M	$15.77M	$10.45M	$14.57M	$14.03M	$13.18M	$13.34M	$13.57M	$13.72M	$13.51M	$12.08M	$2.32M	$1.51M
Surprise %	-	-	-	-	-	-	-	-	0.43%	0.52%	0.67%	0.91%	1.63%	0.99%	1.85%	2.17%	1.48%	0.96%	1.27%	1.33%	1.18%	0.99%	1.04%	1.08%	1.16%	1.21%	1.23%	2.13%	7.10%	8.15%

MannKind's average Quarter SG&A projection for Mar 24 is $33.12M, based on 4 Wall Street analysts, with a range of $26.50M to $39.74M. The forecast indicates a 61.28% rise compared to MNKD last annual SG&A of $20.54M (Dec 23).

MannKind EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	1	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	8	8	8	8	10	15
EPS	-	-	-	-	-	-	-	-	-	$0.01	$-0.02	$-0.06	$-0.09	$-0.08	$-0.12	$-0.12	$-0.13	$-0.02	$-0.14	$-0.05	$-0.11	$-0.05	$-0.05	$-0.04	$-0.07	$-0.05	$-0.07	$-0.08	$-0.25	$-0.17
Avg Forecast	$0.05	$0.05	$0.04	$0.03	$0.03	$0.03	$0.01	$0.03	-	$-0.02	$-0.04	$-0.05	$-0.05	$-0.09	$-0.09	$-0.10	$-0.07	$-0.07	$-0.05	$-0.05	$-0.04	$-0.05	$-0.05	$-0.06	$-0.07	$-0.07	$-0.07	$-0.10	$-0.21	$-0.05
High Forecast	$0.05	$0.05	$0.04	$0.03	$0.03	$0.03	$0.01	$0.03	-	$-0.02	$-0.04	$-0.05	$-0.05	$-0.09	$-0.09	$-0.10	$-0.07	$-0.07	$-0.05	$-0.05	$-0.04	$-0.05	$-0.05	$-0.06	$-0.07	$-0.07	$-0.07	$-0.10	$-0.17	$-0.04
Low Forecast	$0.05	$0.05	$0.04	$0.03	$0.03	$0.03	$0.01	$0.03	-	$-0.02	$-0.04	$-0.05	$-0.05	$-0.09	$-0.09	$-0.10	$-0.07	$-0.07	$-0.05	$-0.05	$-0.04	$-0.05	$-0.05	$-0.06	$-0.07	$-0.07	$-0.07	$-0.10	$-0.25	$-0.05
Surprise %	-	-	-	-	-	-	-	-	1.29%	-0.39%	0.52%	1.21%	1.72%	0.88%	1.28%	1.22%	1.94%	0.30%	3.05%	1.09%	2.80%	1.09%	0.96%	0.69%	1.06%	0.69%	0.93%	0.80%	1.19%	3.40%

According to 4 Wall Street analysts, MannKind's projected average Quarter EPS for Mar 24 is $0.03, with a low estimate of $0.03 and a high estimate of $0.03. This represents a 504.65% increase compared to MNKD previous annual EPS of - (Dec 23).

MannKind Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ELEV	Elevation Oncology	$0.61	$9.00	1375.41%	Buy
SGMO	Sangamo Therapeutics	$1.96	$12.00	512.24%	Buy
IMMP	Immutep	$1.84	$8.50	361.96%	Buy
ADAP	Adaptimmune Therapeutics	$0.64	$2.83	342.19%	Buy
LRMR	Larimar Therapeutics	$6.13	$20.33	231.65%	Buy
DAWN	Day One Biopharmaceuticals	$13.34	$38.80	190.85%	Buy
AFMD	Affimed	$2.64	$7.50	184.09%	Buy
VSTM	Verastem	$3.93	$8.33	111.96%	Buy
LEGN	Legend Biotech	$39.75	$82.69	108.03%	Buy
SABS	SAB Biotherapeutics	$3.07	$5.67	84.69%	Buy
KNSA	Kiniksa Pharmaceuticals	$21.09	$36.33	72.26%	Buy
LQDA	Liquidia	$10.15	$17.17	69.16%	Buy
BMRN	BioMarin Pharmaceutical	$63.45	$101.70	60.28%	Buy
MNKD	MannKind	$6.90	$11.00	59.42%	Buy
PCVX	Vaxcyte	$88.39	$124.00	40.29%	Buy
TECH	Bio-Techne	$71.05	$91.69	29.05%	Buy
UTHR	United Therapeutics	$367.36	$358.20	-2.49%	Buy

MNKD Forecast FAQ

Is MannKind a good buy?

Yes, according to 3 Wall Street analysts, MannKind (MNKD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of MNKD's total ratings.

What is MNKD's price target?

MannKind (MNKD) average price target is $11 with a range of $10 to $12, implying a 59.42% from its last price of $6.9. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will MannKind stock go up soon?

According to Wall Street analysts' prediction for MNKD stock, the company can go up by 59.42% (from the last price of $6.9 to the average price target of $11), up by 73.91% based on the highest stock price target, and up by 44.93% based on the lowest stock price target.

Can MannKind stock reach $10?

MNKD's average twelve months analyst stock price target of $11 supports the claim that MannKind can reach $10 in the near future.

What are MannKind's analysts' financial forecasts?

MannKind's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $272.69M (high $276.85M, low $268.63M), average EBITDA is $-141M (high $-133M, low $-149M), average net income is $-22.813M (high $-14.231M, low $-31.348M), average SG&A $224.38M (high $234.76M, low $214.1M), and average EPS is $0.092 (high $0.0933, low $0.0909). MNKD's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $321.4M (high $324.84M, low $318.57M), average EBITDA is $-167M (high $-165M, low $-169M), average net income is $48.4M (high $49.07M, low $47.84M), average SG&A $289.76M (high $292.87M, low $287.21M), and average EPS is $0.17 (high $0.172, low $0.168).

Did the MNKD's actual financial results beat the analysts' financial forecasts?

Based on MannKind's last annual report (Dec 2023), the company's revenue was $198.96M, beating the average analysts forecast of $184.58M by 7.79%. Apple's EBITDA was $8.68M, missing the average prediction of $-101M by -108.61%. The company's net income was $-11.938M, missing the average estimation of $-47.473M by -74.85%. Apple's SG&A was $94.31M, missing the average forecast of $158.88M by -40.64%. Lastly, the company's EPS was $-0.0447, missing the average prediction of $-0.101 by -55.96%. In terms of the last quarterly report (Dec 2023), MannKind's revenue was $58.47M, beating the average analysts' forecast of $53.5M by 9.29%. The company's EBITDA was $10.63M, missing the average prediction of $-27.775M by -138.29%. MannKind's net income was $1.4M, beating the average estimation of $948.88K by 47.65%. The company's SG&A was $20.54M, missing the average forecast of $48.24M by -57.43%. Lastly, the company's EPS was $0.0043, beating the average prediction of $0.00333 by 29.01%